Solamargine

CAS No. 20311-51-7

Solamargine( Solamargin | δ-Solanigrine )

Catalog No. M17419 CAS No. 20311-51-7

Solamargine is a major steroidal alkaloid glycoside extracted from a traditional Chinese medicine herb, Solanum nigrum L. (SNL); has been shown to inhibit growth and induce apoptosis of various cancer cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 105 In Stock
10MG 159 In Stock
25MG 327 In Stock
50MG 506 In Stock
100MG 711 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Solamargine
  • Note
    Research use only, not for human use.
  • Brief Description
    Solamargine is a major steroidal alkaloid glycoside extracted from a traditional Chinese medicine herb, Solanum nigrum L. (SNL); has been shown to inhibit growth and induce apoptosis of various cancer cells.
  • Description
    Solamargine is a major steroidal alkaloid glycoside extracted from a traditional Chinese medicine herb, Solanum nigrum L. (SNL); has been shown to inhibit growth and induce apoptosis of various cancer cells.
  • In Vitro
    Solamargine (15 μg/ml; 72 hours) predominantly stimulates the cells of the G2/M phase to apoptosis.Solamargine (72 hours) dramatically inhibits the proliferation of SMMC-7721 and HepG2 cells in a dose- and time-dependent manner. The IC50s are 9.21 and 19.88 μg/ml, respectively. Cell Viability Assay Cell Line:SMMC-7721cells Concentration:15 μg/ml.Incubation Time:72 hours Result:Displayed a significant increase of sub-G1.
  • In Vivo
    Solamargine (10 mg/kg; intragastric administration; once daily for 8 days) exhibits an antitumor effect and promotes the apoptosis of GC in vivo. Animal Model:Female specific pathogen-free BALB/c nude mice weighing 18-20 g (6-8-weeks-old) Dosage:10 mg/kg Administration:Intragastric administration; once daily for 8 days Result:Tumor growth was significantly inhibited .
  • Synonyms
    Solamargin | δ-Solanigrine
  • Pathway
    Angiogenesis
  • Target
    PKC
  • Recptor
    p38 MAPK| STAT3
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    20311-51-7
  • Formula Weight
    868.07
  • Molecular Formula
    C45H73NO15
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 8.8 mg/mL; 10.14 mM
  • SMILES
    [C@H]1([C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5O[C@]6([C@H]([C@@H]5[C@]4(CC[C@@H]3[C@]2(CC1)C)C)C)NC[C@@H](CC6)C)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sani IK., et al. Toxicol In Vitro. 2015 Aug;29(5):893-900.
molnova catalog
related products
  • Protein kinase inhib...

    Protein kinase inhibitor H-7 is a potent inhibitor of protein kinase C (PKC) with a Ki of 6 μM. Protein kinase inhibitor H-7 is also a cyclic nucleotide dependent protein kinase inhibitor.

  • Protein Kinase C 19-...

    Protein Kinase C (19-36) is a pseudosubstrate peptide inhibitor of protein kinase C (PKC), with an IC50 of 0.18 μM.

  • Bisindolylmaleimide ...

    Bisindolylmaleimide VIII (Ro-31-7549) is a selective and potent protein kinase C (PKC) inhibitor with good inhibition of PKC-α, PKC-β I, PKC-β II, PKC-γ, and PKC-ε.